NELFB
Basic information
Region (hg38): 9:137255327-137273542
Previous symbols: [ "COBRA1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NELFB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 46 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 1 | 0 |
Variants in NELFB
This is a list of pathogenic ClinVar variants found in the NELFB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137255546-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
9-137255917-G-C | not specified | Uncertain significance (Oct 17, 2023) | ||
9-137255931-T-G | not specified | Uncertain significance (Oct 20, 2024) | ||
9-137255958-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
9-137256343-A-C | not specified | Uncertain significance (Apr 25, 2022) | ||
9-137256396-G-C | not specified | Uncertain significance (Feb 08, 2025) | ||
9-137256424-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
9-137256834-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
9-137256846-T-A | not specified | Uncertain significance (Oct 16, 2024) | ||
9-137256915-A-C | not specified | Uncertain significance (Jun 18, 2021) | ||
9-137256944-C-A | not specified | Uncertain significance (Aug 21, 2023) | ||
9-137263041-T-C | not specified | Uncertain significance (May 05, 2023) | ||
9-137263128-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
9-137263146-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
9-137263209-A-T | not specified | Uncertain significance (Jan 22, 2025) | ||
9-137263212-C-A | not specified | Uncertain significance (Mar 20, 2023) | ||
9-137264260-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
9-137264261-A-T | not specified | Uncertain significance (Dec 07, 2024) | ||
9-137264273-G-C | not specified | Uncertain significance (May 04, 2022) | ||
9-137264333-A-G | not specified | Uncertain significance (Dec 12, 2023) | ||
9-137265959-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
9-137266340-G-A | not specified | Uncertain significance (Sep 24, 2024) | ||
9-137266358-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
9-137266972-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
9-137267011-A-G | not specified | Uncertain significance (Dec 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NELFB | protein_coding | protein_coding | ENST00000343053 | 13 | 18374 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00339 | 0.996 | 125724 | 0 | 19 | 125743 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 271 | 360 | 0.753 | 0.0000227 | 3751 |
Missense in Polyphen | 85 | 128.05 | 0.6638 | 1340 | ||
Synonymous | -1.41 | 196 | 172 | 1.14 | 0.0000120 | 1188 |
Loss of Function | 3.09 | 9 | 26.0 | 0.346 | 0.00000126 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000190 | 0.000181 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex. The NELF complex is involved in HIV-1 latency possibly involving recruitment of PCF11 to paused RNA polymerase II. Binds RNA which may help to stabilize the NELF complex on nucleic acid. In vitro, binds weakly to the HIV-1 TAR RNA which is located in the long terminal repeat (LTR) of HIV-1. May be able to induce chromatin unfolding. {ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:12612062, ECO:0000269|PubMed:23884411, ECO:0000269|PubMed:27282391}.;
- Pathway
- Initiation of transcription and translation elongation at the HIV-1 LTR;Disease;Formation of the HIV-1 Early Elongation Complex;Gene expression (Transcription);Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Abortive elongation of HIV-1 transcript in the absence of Tat;HIV Transcription Elongation;HIV elongation arrest and recovery;Formation of HIV elongation complex in the absence of HIV Tat;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Tat-mediated HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Transcription Elongation;TP53 Regulates Transcription of DNA Repair Genes;Transcriptional Regulation by TP53;Formation of the Early Elongation Complex
(Consensus)
Recessive Scores
- pRec
- 0.275
Intolerance Scores
- loftool
- rvis_EVS
- -1.35
- rvis_percentile_EVS
- 4.56
Haploinsufficiency Scores
- pHI
- 0.132
- hipred
- Y
- hipred_score
- 0.714
- ghis
- 0.627
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nelfb
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- nelfb
- Affected structure
- hematopoietic multipotent progenitor cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;negative regulation of transcription elongation from RNA polymerase II promoter
- Cellular component
- nucleoplasm;cytoplasm;NELF complex
- Molecular function
- RNA binding;protein binding